Description

BSE announces changes to the Long Term ASM Framework effective March 06, 2026, including 3 new securities shortlisted, 1 security moved to higher stage, and 2 securities removed from the framework.

Summary

BSE has announced updates to the Long Term Additional Surveillance Measure (LT-ASM) Framework effective March 06, 2026. Three new securities have been shortlisted under the framework, one security has been moved to a higher ASM stage, and two securities have been removed from the LT-ASM framework due to inclusion in other surveillance frameworks (GSM and ESM).

Key Points

  • 3 new securities added to Long Term ASM Framework (Part A) effective March 06, 2026
  • 1 security (Elango Industries Ltd) moved to a higher ASM Stage II (Part B)
  • No securities moved to lower ASM stages (Part C: Nil)
  • No securities shortlisted directly in Stage IV LT-ASM (Part D: Nil)
  • 2 securities moving out of LT-ASM Framework (Annexure II)
  • A consolidated list of all securities currently under LT-ASM is provided in Annexure III

Regulatory Changes

New Entrants to LT-ASM (Part A — effective March 06, 2026):

Sr. No.Scrip CodeISINScrip Name
1512048INE195E01020Dhansafal Finserve Ltd
2531360INE427D01011Golechha Global Finance Ltd
3540729INE695X01011Vanta Bioscience Ltd

Securities Moving to Higher ASM Stage (Part B):

Sr. No.Scrip CodeISINScrip NameMoved to Stage
11513452INE594D01018Elango Industries LtdStage II

Securities Exiting LT-ASM Framework (Annexure II):

Sr. No.Scrip CodeISINScrip NameReason
1524642INE528E01022Sikozy Realtors LtdMoved to GSM Framework
2533407INE672K01025True Green Bio Energy LtdMoved to ESM Framework

Compliance Requirements

  • Trading members and investors must note the revised ASM applicability for affected securities from March 06, 2026
  • Securities under LT-ASM are subject to additional margin requirements and trading restrictions as per the applicable ASM stage
  • Broker systems should be updated to reflect the new stage assignments and framework changes before market open on March 06, 2026
  • Investors holding positions in newly added or stage-upgraded securities should review applicable margin and settlement obligations

Important Dates

  • Effective Date: March 06, 2026 — All changes to LT-ASM framework become applicable
  • Circular Date: March 05, 2026

Impact Assessment

The inclusion of Dhansafal Finserve Ltd, Golechha Global Finance Ltd, and Vanta Bioscience Ltd in LT-ASM will result in enhanced surveillance, higher margin requirements, and potential trading restrictions for these securities. Investors and traders in these scrips will face increased compliance burden and possible liquidity constraints.

Elango Industries Ltd faces tighter restrictions following its move to Stage II LT-ASM, which typically entails stricter margin requirements than Stage I.

Sikozy Realtors Ltd and True Green Bio Energy Ltd exit LT-ASM but transition into the GSM and ESM frameworks respectively, meaning surveillance oversight continues under different regulatory mechanisms.

The consolidated list in Annexure III confirms continued LT-ASM applicability across a large number of securities, maintaining broad market surveillance coverage across multiple stages.

Impact Justification

Directly affects trading conditions for multiple listed securities by placing them under enhanced surveillance, moving securities between ASM stages, and removing some from the framework — all with immediate market impact from March 06, 2026.